Hughes Hubbard life sciences chief Patrice Jean says that, given the complexity that goes into some pharmaceuticals, it’s “understandable that you would have dozens of patents that potentially cover what the outcome is.”
Skilled in the Art With Scott Graham: In Defense of Patent Thickets + Gaming Out a Year of Section 101 Limbo + Bad Takes From a PTAB Reform Hearing
Leave a Reply